The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I/R Injury
Open accessAbstract
Rationale: Pyroptosis is a morphologically and mechanistically distinct form of cell death and is characterized by GSDMD (gasdermin D) or GSDME (gasdermin E)-mediated necrosis with excessive inflammatory factor release. Cardiomyocyte necrosis and inflammation play key roles in the pathophysiology of myocardial ischemia/reperfusion (I/R) injury. However, whether cardiomyocytes undergo pyroptosis and the underlying mechanism in myocardial I/R injury remain unclear. Objective: We aimed to investigate the role of pyroptosis in myocardial I/R injury. Methods and Results: In vivo and in vitro experiments were used to investigate pyroptosis of cardiomyocyte and the associated mechanisms during I/R injury. Wild-type, Myh6-Cre, and cardiomyocyte-specific GSDMD-deficient male mice were subjected to I/R. Human peripheral blood samples were collected from patients with acute ST-segment–elevation myocardial infarction or control patients at 0, 1, and 24 hours after percutaneous coronary intervention in our department. The serum levels of GSDMD were measured by ELISA. Hypoxia/reoxygenation induced cardiomyocyte pyroptosis and the release of mature IL (interleukin)-18 but not IL-1β, which mechanistically resulted from GSDMD cleavage by caspase-11 in cardiomyocytes. Furthermore, GSDMD gene deletion blocked hypoxia/reoxygenation-induced cardiomyocyte pyroptosis and IL-18 release. GSDMD and its pyroptosis-inducing N-terminal fragment were upregulated in myocardial tissues after I/R injury. Immunofluorescence analysis showed that GSDMD was mainly localized in cardiomyocytes. GSDMD deficiency in cardiomyocytes significantly reduced the I/R-induced myocardial infarct size. Moreover, increased GSDMD serum levels were detected in patients exhibiting I/R injury 1 hour after percutaneous coronary intervention for ST-segment–elevation myocardial infarction. Conclusions: Our results show that GSDMD-mediated cardiomyocyte pyroptosis is a key event during myocardial I/R injury and that the caspase-11/GSDMD pathway may be essential to this process. Additionally, GSDMD inhibition significantly reduces cardiomyocyte pyroptosis and I/R-induced myocardial injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
Wyllie, A. H. (1980) · Nature · doi:10.1038/284555a0 · Cited by 4,504
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., et al. (2015) · Nature · doi:10.1038/nature15541 · Cited by 3,686
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V. G., Wu, H., & Lieberman, J. (2016) · Nature · doi:10.1038/nature18629 · Cited by 3,202
Pyroptosis: host cell death and inflammation
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,183
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Shi, J., Gao, W., & Shao, F. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.004 · Cited by 3,088
Pore-forming activity and structural autoinhibition of the gasdermin family
Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Sun, H., Wang, D.-C., & Shao, F. (2016) · Nature · doi:10.1038/nature18590 · Cited by 2,771
Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
He, W.-T., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., Yang, Z.-H., Zhong, C.-Q., & Han, J. (2015) · Cell Research · doi:10.1038/cr.2015.139 · Cited by 2,517
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Hausenloy, D. J., & Yellon, D. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62874 · Cited by 2,357
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742c84 · Cited by 2,250
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., & Wang, X. (2009) · Cell · doi:10.1016/j.cell.2009.05.021 · Cited by 2,214
Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells
Fink, S. L., & Cookson, B. T. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.1907-1916.2005 · Cited by 2,205
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.018 · Cited by 1,772
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
Heusch, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0403-y · Cited by 1,234
GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
Sborgi, L., Rühl, S., Mulvihill, E., Pipercevic, J., Heilig, R., Stahlberg, H., Farady, C. J., Müller, D. J., Broz, P., & Hiller, S. (2016) · The EMBO Journal · doi:10.15252/embj.201694696 · Cited by 1,152
Pyroptotic cell death defends against intracellular pathogens
Jorgensen, I., & Miao, E. A. (2015) · Immunological Reviews · doi:10.1111/imr.12287 · Cited by 1,021
Evolving Therapies for Myocardial Ischemia/Reperfusion Injury
Ibáñez, B., Heusch, G., Ovize, M., & Van de Werf, F. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.032 · Cited by 1,009
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes
Aglietti, R. A., Estevez, A., Gupta, A., Ramirez, M. G., Liu, P. S., Kayagaki, N., Ciferri, C., Dixit, V. M., & Dueber, E. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607769113 · Cited by 898
Kawaguchi, M., Takahashi, M., Hata, T., Kashima, Y., Usui, F., Morimoto, H., Izawa, A., Takahashi, Y., Masumoto, J., Koyama, J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.982777 · Cited by 884
Chen, X., He, W.-T., Hu, L., Li, J., Fang, Y., Wang, X., Xu, X., Wang, Z., Huang, K., & Han, J. (2016) · Cell Research · doi:10.1038/cr.2016.100 · Cited by 831
Self-citationCell Death in the Pathogenesis of Heart Disease: Mechanisms and Significance
Whelan, R. S., Kaplinskiy, V., & Kitsis, R. N. (2010) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163111 · Cited by 759
Ferroptosis as a novel therapeutic target for cardiovascular disease
Wu, X., Li, Y., Zhang, S., & Zhou, X. (2021) · Theranostics · doi:10.7150/thno.54113 · Cited by 647
Self-citationA fresh look at reperfusion injury
Piper, H. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00033-9 · Cited by 609
Gracie, J. A., Robertson, S. E., & McInnes, I. B. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602313 · Cited by 603
Ackers-Johnson, M., Li, P. Y., Holmes, A. P., O’Brien, S.-M., Pavlovic, D., & Foo, R. S. (2016) · Circulation Research · doi:10.1161/circresaha.116.309202 · Cited by 543
Suzuki, T., Franchi, L., Toma, C., Ashida, H., Ogawa, M., Yoshikawa, Y., Mimuro, H., Inohara, N., Sasakawa, C., & Nuñez, G. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030111 · Cited by 535
Myocardial ischemia and reperfusion: a murine model
Michael, L. H., Entman, M. L., Hartley, C. J., Youker, K. A., Zhu, J., Hall, S. R., Hawkins, H. K., Berens, K., & Ballantyne, C. M. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.6.h2147 · Cited by 435
Recent Insights into the Molecular Mechanisms Underlying Pyroptosis and Gasdermin Family Functions
Aglietti, R. A., & Dueber, E. C. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.003 · Cited by 407
Overview of interleukin-18: more than an interferon-γ inducing factor
Dinarello, C. A., Novick, D., Puren, A. J., Fantuzzi, G., Shapiro, L., Mühl, H., Yoon, D.-Y., Reznikov, L. L., Kim, S.-H., & Rubinstein, M. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.6.658 · Cited by 374
Caspases Connect Cell-Death Signaling to Organismal Homeostasis
Galluzzi, L., López-Soto, A., Kumar, S., & Kroemer, G. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.020 · Cited by 350
The role of IL-1 in the pathogenesis of heart disease
Bujak, M., & Frangogiannis, N. G. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0024-y · Cited by 307
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
Sager, H. B., Heidt, T., Hulsmans, M., Dutta, P., Courties, G., Sebas, M., Wojtkiewicz, G. R., Tricot, B., Iwamoto, Y., Sun, Y., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016160 · Cited by 253
Gender-based differences in mechanisms of protection in myocardial ischemia–reperfusion injury
MURPHY, E., & STEENBERGEN, C. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.025 · Cited by 251
Oncosis: An important non-apoptotic mode of cell death
Weerasinghe, P., & Buja, L. M. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.09.018 · Cited by 244
Oncogene-induced senescence and tumour control in complex biological systems
Galluzzi, L., & Vitale, I. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-018-0102-y · Cited by 242
Oxidative stress-elicited myocardial apoptosis during reperfusion
Zhao, Z. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.10.010 · Cited by 188
Regulated cell death and adaptive stress responses
Galluzzi, L., Bravo-San Pedro, J. M., Kepp, O., & Kroemer, G. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2209-y · Cited by 177
Gasdermin D: the long-awaited executioner of pyroptosis
Man, S. M., & Kanneganti, T. (2015) · Cell Research · doi:10.1038/cr.2015.124 · Cited by 167
Pore formation by GSDMD is the effector mechanism of pyroptosis
Gaidt, M. M., & Hornung, V. (2016) · The EMBO Journal · doi:10.15252/embj.201695415 · Cited by 162
Buller, C. E. H., Fu, Y., Mahaffey, K. W., Todaro, T. G., Adams, P. X., Westerhout, C. M., White, H. D., Hof, A. W. J. V. ’., de Werf, F. V., Wagner, G. S., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.767772 · Cited by 152
The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury
Steffens, S., Montecucco, F., & Mach, F. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-12-0837 · Cited by 151
Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury
Venkatachalam, K., Prabhu, S. D., Reddy, V. S., Boylston, W. H., Valente, A. J., & Chandrasekar, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808824200 · Cited by 137
Sex‐based differences in cardiac ischaemic injury and protection: therapeutic implications
Ošťádal, B., & Ostadal, P. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12270 · Cited by 97
Jujo, K., Ii, M., Sekiguchi, H., Klyachko, E. A., Misener, S., Tanaka, T. D., Tongers, J., Roncalli, J. G., Renault, M., Thorne, T., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.099242 · Cited by 93
TNF-α and H2O2 induce IL-18 and IL-18Rβ expression in cardiomyocytes via NF-κB activation
Chandrasekar, B., Colston, J. T., de la Rosa, S. D., Perla, R. P., & Freeman, G. L. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00496-0 · Cited by 89
Wang, M., Markel, T. A., & Meldrum, D. R. (2008) · Shock · doi:10.1097/shk.0b013e318160f215 · Cited by 68
Xie, L., Pi, X., Wang, Z., He, J., Willis, M. S., & Patterson, C. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.007 · Cited by 62
Self-citationShiokawa, D., Maruta, H., & Tanuma, S.-I. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00887-9 · Cited by 62
Necrosis, Apoptosis, Necroptosis, Pyroptosis: It Matters How Acinar Cells Die During Pancreatitis
Sendler, M., Mayerle, J. V., & Lerch, M. M. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.05.007 · Cited by 52
Pyroptosis as a Regulated Form of Necrosis
Abe, J., & Morrell, C. N. (2016) · Circulation Research · doi:10.1161/circresaha.116.308699 · Cited by 50
Bouma, W., Noma, M., Kanemoto, S., Matsubara, M., Leshnower, B. G., Hinmon, R., Gorman, J. H., & Gorman, R. C. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01021.2009 · Cited by 40
Adiponectin and ischemia-reperfusion injury in ST segment elevation myocardial infarction
Roeck, L. D., Vandamme, S., Everaert, B., Hoymans, V. Y., Haine, S. E. F., Vandendriessche, T. R., Bosmans, J. M., Ronsyn, M. W., Miljoen, H., Berendoncks, A. V., et al. (2015) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872615570770 · Cited by 19
Cited by
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
“Hypoxia/reoxygenation induces cardiomyocyte pyroptosis and IL-18 release, which is mediated by caspase 11-mediated cleavage of GSDMD.(126) Strikingly, HIF-1 plays a key role in pyroptosis based on NLRP3 inflammasome.”
BackgroundRegulated cell death in myocardial ischemia–reperfusion injury
Xiang, Q., Yi, X., Zhu, X.-H., Wei, X., & Jiang, D.-S. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2023.10.010 · Cited by 448
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
Liu, Y., Pan, R., Ouyang, Y., Gu, W., Xiao, T., Yang, H., Tang, L., Wang, H., Xiang, B., & Chen, P. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01958-2 · Cited by 337
Targeting the NLRP3 inflammasome in cardiovascular diseases
Toldo, S., Mezzaroma, E., Buckley, L. F., Potere, N., Di Nisio, M., Biondi-Zoccai, G., Van Tassell, B. W., & Abbate, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108053 · Cited by 328
GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis
Wei, Y., Lan, B., Zheng, T., Yang, L., Zhang, X., Cheng, L., Tuerhongjiang, G., Yuan, Z., & Wu, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-36614-w · Cited by 275
Metadata
- Authors
- Shi, H., Gao, Y., Dong, Z., Yang, J., Gao, R., Li, X., Zhang, S., Ma, L., Sun, X., Wang, Z., Zhang, F., Hu, K., Sun, A., & Ge, J.
- Venue
- Circulation Research
- Published
- 2021-07-23
- Volume
- 129
- Issue
- 3
- Pages
- 383-396
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W3161208341
- Cited by
- 335
- References
- 55
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.